2.1 Lower urinary tract symptoms caused by benign prostatic hyperplasia commonly affect men over 50. Stromal and epithelial cells increase in number, causing the prostate to increase in size. It often ...

The National Institute for Clinical Excellence is examining transurethral electrovaporisation of the prostate and will publish guidance on its safety and efficacy to the NHS in England and Wales. The ...

Transurethral resection of the prostate (TURP) is the gold standard treatment for obstructing benign prostatic hyperplasia (BPH), but it is limited to prostates weighing less than 100 g and is ...

Exposure to harmful gases in the operating room (OR) is an occupational risk for healthcare personnel, but this issue remains insufficiently recognized in transurethral resection (TUR) procedures.

More than 250,000 people undergo a transurethral procedure each year in the U.S., and up to 10% of those people will experience a postoperative infection. But researchers have discovered an indicator ...

NHS savings could equate to millions of pounds per year, whilst reducing risks leading to better patient outcomes. New guidance has been released today by the National Institute for Health and Care ...

Some studies show that use of transurethral resection of the prostate, long the gold standard for managing enlarged prostates, is in decline, but it still remains the most popular choice among ...

Survey on management of metastatic hormone-refractory prostate cancer upon progression during or following first-line chemotherapy in five European countries. Background: About 20 to 30% of men with ...

An enlarged prostate, known as benign prostatic hyperplasia (BPH), is a common condition often associated with the natural aging process in men. Dr. Scott Cheney, a Mayo Clinic urologist, says it's a ...